Singapore markets closed

MRK Jan 2025 65.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
48.450.00 (0.00%)
As of 02:48PM EDT. Market open.
Full screen
Previous close48.45
Open48.45
Bid60.00
Ask63.95
Strike65.00
Expiry date2025-01-17
Day's range48.45 - 48.45
Contract rangeN/A
Volume10
Open interest14
  • Simply Wall St.

    Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

  • Benzinga

    Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study

    On Friday, Summit Therapeutics Inc (NASDAQ:SMMT) shares are trading lower after the company’s stock closed 272.1% higher at $10.92 on Thursday. Thursday, Summit Therapeutics Inc (NASDAQ:SMMT) announced that Phase 3 HARMONi-2, or AK112-303, met its primary endpoint of progression-free survival (PFS). HARMONi-2 evaluated monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have positive PD-L1 expre

  • Reuters SG

    Deals of the day-Mergers and acquisitions

    ** Prolific oil and gas developer Double Eagle is exploring a sale of its latest Permian Basin-based producer in a deal that could be worth more than $6.5 billion, including debt, according to people familiar with the matter. ** The owner of Britain's Royal Mail has agreed to a 3.57 billion pound ($4.55 billion) takeover by Czech billionaire Daniel Kretinsky, in a take-private deal of one of the world's oldest postal firms.